260 related articles for article (PubMed ID: 33641024)
1. Liquid Biopsy in Gastrointestinal Stromal Tumors: Ready for Prime Time?
Gómez-Peregrina D; García-Valverde A; Pilco-Janeta D; Serrano C
Curr Treat Options Oncol; 2021 Feb; 22(4):32. PubMed ID: 33641024
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors.
Serrano C; Vivancos A; López-Pousa A; Matito J; Mancuso FM; Valverde C; Quiroga S; Landolfi S; Castro S; Dopazo C; Sebio A; Virgili AC; Menso MM; Martín-Broto J; Sansó M; García-Valverde A; Rosell J; Fletcher JA; George S; Carles J; Arribas J
BMC Cancer; 2020 Feb; 20(1):99. PubMed ID: 32024476
[TBL] [Abstract][Full Text] [Related]
3. Latest advances in adult gastrointestinal stromal tumors.
Florou V; Wilky BA; Trent JC
Future Oncol; 2017 Oct; 13(24):2183-2193. PubMed ID: 28984483
[TBL] [Abstract][Full Text] [Related]
4. Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA.
Gómez-Peregrina D; Cicala CM; Serrano C
Curr Opin Oncol; 2024 Jul; 36(4):282-290. PubMed ID: 38726808
[TBL] [Abstract][Full Text] [Related]
5. Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward.
Lostes-Bardaji MJ; García-Illescas D; Valverde C; Serrano C
Ther Adv Med Oncol; 2021; 13():1758835920986498. PubMed ID: 33473249
[TBL] [Abstract][Full Text] [Related]
6. Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST).
Jilg S; Rassner M; Maier J; Waldeck S; Kehl V; Follo M; Philipp U; Sauter A; Specht K; Mitschke J; Lange T; Bauer S; Jost PJ; Peschel C; Duyster J; Gaiser T; Hohenberger P; von Bubnoff N
Int J Cancer; 2019 Oct; 145(8):2292-2303. PubMed ID: 30882891
[TBL] [Abstract][Full Text] [Related]
7. [The importance of mutational status in prognosis and therapy of GIST].
Comandone A; Boglione A
Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
[TBL] [Abstract][Full Text] [Related]
8. Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors.
Bannon AE; Klug LR; Corless CL; Heinrich MC
Expert Rev Mol Diagn; 2017 May; 17(5):445-457. PubMed ID: 28317407
[TBL] [Abstract][Full Text] [Related]
9. Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors.
Roulleaux Dugage M; Jones RL; Trent J; Champiat S; Dumont S
Front Immunol; 2021; 12():715727. PubMed ID: 34489967
[TBL] [Abstract][Full Text] [Related]
10. Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors.
Yan W; Zhang A; Powell MJ
Chin J Cancer; 2016 Jul; 35(1):68. PubMed ID: 27443349
[TBL] [Abstract][Full Text] [Related]
11. Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors.
Serrano C; George S; Valverde C; Olivares D; García-Valverde A; Suárez C; Morales-Barrera R; Carles J
Target Oncol; 2017 Jun; 12(3):277-288. PubMed ID: 28478525
[TBL] [Abstract][Full Text] [Related]
12. Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates.
Farag S; Smith MJ; Fotiadis N; Constantinidou A; Jones RL
Curr Treat Options Oncol; 2020 May; 21(7):55. PubMed ID: 32462367
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumor (GIST) pathogenesis, familial GIST, and animal models.
Antonescu CR
Semin Diagn Pathol; 2006 May; 23(2):63-9. PubMed ID: 17193819
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor.
García-Valverde A; Rosell J; Serna G; Valverde C; Carles J; Nuciforo P; Fletcher JA; Arribas J; Politz O; Serrano C
Mol Cancer Ther; 2020 Jun; 19(6):1289-1297. PubMed ID: 32371592
[TBL] [Abstract][Full Text] [Related]
16. [Translational research and diagnosis in GIST].
Wardelmann E
Pathologe; 2012 Nov; 33 Suppl 2():273-7. PubMed ID: 22968735
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumors: key to diagnosis and choice of therapy.
Rutkowski P; Debiec-Rychter M; Ruka W
Mol Diagn Ther; 2008; 12(3):131-43. PubMed ID: 18510377
[TBL] [Abstract][Full Text] [Related]
18. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors.
Wang CM; Huang K; Zhou Y; Du CY; Ye YW; Fu H; Zhou XY; Shi YQ
J Cancer Res Clin Oncol; 2010 Jul; 136(7):1065-71. PubMed ID: 20043176
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide functional screening identifies CDC37 as a crucial HSP90-cofactor for KIT oncogenic expression in gastrointestinal stromal tumors.
Mariño-Enríquez A; Ou WB; Cowley G; Luo B; Jonker AH; Mayeda M; Okamoto M; Eilers G; Czaplinski JT; Sicinska E; Wang Y; Taguchi T; Demetri GD; Root DE; Fletcher JA
Oncogene; 2014 Apr; 33(14):1872-6. PubMed ID: 23584476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]